-

Drugs

  • Share Share this page

Individual Product Bioequivalence Recommendations: Active Ingredients Starting with 'N'

 

Dissolutions Methods Database

 

Individual Product Bioequivalence Recommendations Arranged by Active Ingredient
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

 

Active Ingredient
(link to Specific Guidance)
Type Route of Administration Dosage Form RLD Application Number
(link to Orange Book)
Date
Recommended
Nabilone
Revised
Draft Oral Capsule 18677 7/2009
Nabumetone Final Oral Tablet 75189 5/2008
Nadolol Draft Oral Tablet 18063 5/2009
Naltrexone Draft Intramuscular Suspension, Extended Release 21897 8/2009
Naproxen Draft Oral Tablet 17581 7/2008
Naproxen Sodium Draft Oral Tablet 18164 7/2008
Naproxen Sodium Draft Oral Tablet 20204 7/2008
Naratriptan HCl Draft Oral Tablet 20763 7/2008
Nateglinide Final Oral Tablet 21204 5/2008
Nelfinavir Mesylate Draft Oral Suspension 20778 11/2007
Nelfinavir Mesylate Final Oral Tablet

20779

21503

5/2008
Nevirapine Final Oral Suspension 20933 5/2008
Nevirapine Draft Oral Tablet 20636 11/2007
Nicardipine HCl Draft Oral Capsule, Extended Release 20005 7/2008
Nifedipine Draft Oral Tablet, Extended Release 19684 3/2009
Nilutamide Draft Oral Tablet 20169 8/2009
Nisoldipine Draft Oral Tablet, Extended Release 20356 5/2009
Nitazoxanide Draft Oral Tablet 21497 8/2009
Nitrofurantoin Draft Oral Suspension 09175 4/2009
Nitrofurantoin Macrocrystalline Draft Oral Capsule 16620 4/2009
Norethindrone Draft Oral Tablet 16954 4/2009
Norethindrone Acetate Draft Oral Tablet 18405 3/2009
    
-
-
-
-
-